ID 211 - Niacyna

PL: Niacyna
EN: Nacin
Pdf: niacin

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claims is niacin, which is a well recognised nutrient and is measurable in foods by established methods.
Preformed niacin occurs naturally in foods either as nicotinamide, as derived pyridine nucleotide coenzymes (nicotinamide adenine dinucleotide, NAD and nicotinamide adenine dinucleotide phosphate, NADP) or as nicotinic acid. Niacin can also be synthesised in the body from dietary tryptophan. Niacin is the common term for nicotinamide and nicotinic acid and is authorised for addition to foods (Annex I of the Regulation (EC) No 1925/20066 and Annex I of Directive 2002/46/EC7). This evaluation applies to niacin naturally present in foods and those forms authorised for addition to foods (Annex II of Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, niacin, which is the subject of the health claims is sufficiently characterised.

2.4. Utrzymanie prawidłowego przepływu krwi (ID 211)

The claimed effect is “niacin enhances the blood flow because of its vascular dilatation effect”. The Panel assumes that the target population is the general population.
The Panel considers that maintenance of normal blood flow is a beneficial physiological effect.

3.3. Utrzymanie prawidłowego przepływu krwi (ID 211)

Five references were cited to substantiate the claim, two of which were textbooks where the claimed effect was not mentioned, and one of which was related to dietary reference values for vitamins and minerals from an authoritative body. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claimed effect.
In the remaining two textbooks the effect of nicotinic acid at daily doses of at least 30 mg on vasodilatation was mentioned. The Panel notes that this dose of nicotinic acid is above the Tolerable Upper Intake level (UL) (10 mg; SCF, 2002).
The Panel considers that this claim (the proposed wording of this claim) encourages excess consumption of niacin and therefore does not comply with the criteria laid down in Regulation (EC) No 1924/2006.

5. Warunki i możliwe ograniczenia stosowania oświadczenia

The Panel considers that in order to bear the claims a food should be at least a source of niacin as per Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population. Tolerable Upper Intake Levels (ULs) have been established for free nicotinic acid and nicotinamide (SCF, 2002).

Warunki i możliwe ograniczenia stosowania oświadczenia

yes